Back to News
Market Impact: 0.35

SSE: Funded Regulated Asset Value Growth Offers Nice Upside

Company FundamentalsRegulation & LegislationEnergy Markets & PricesCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)
SSE: Funded Regulated Asset Value Growth Offers Nice Upside

SSE plc plans its largest investment phase, targeting £33B through FY2030, with 80% earmarked for regulated electricity networks. Management expects the Regulated Networks to drive most earnings, targeting the RAV to rise from £15.6B to £40B by FY2030, alongside guidance of 225–250p adjusted EPS by FY2030. The company frames this as offering ~59% total return potential over four years (assuming a 15x PE and dividends).

Analysis

This is less a near-term earnings upgrade than a duration trade on the regulator’s willingness to let the asset base compound. The market should focus on whether the implied equity return can survive a multi-year phase of heavy capex without eroding the balance sheet; in utility land, the biggest risk is often not operational execution but financing cost plus regulatory lag. If UK real rates stay elevated, the present value of those future regulated cash flows compresses even if the RAV trajectory is achieved.

Relative winners are the domestic supply-chain names tied to grid buildout—cable, switchgear, transformers, EPC—and the broader UK power-network complex if this becomes a multi-year capex supercycle. Relative losers are long-duration utilities with less visible regulatory support or weaker asset-growth paths, because SSE’s commitment raises the bar on peer disclosures around allowed returns and self-funded growth. National Grid is the obvious comparator: if SSE can convert RAV growth into EPS while maintaining dividends, it pressures peers to explain why their own network assets deserve a lower multiple.

The contrarian issue is that the consensus may be extrapolating the end-state multiple before the funding bridge is visible. A 15x terminal P/E is plausible only if the market becomes comfortable that debt, equity issuance, and regulatory outcomes do not dilute the accretion from higher RAV. The stock can still underperform on the way up if investors decide the capex cycle is value-destructive in the next 12 months, even if it is value-accretive by FY2030.

More News